John Vavricka - Chief Commercial Officer at Atea Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
AVIR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Vavricka since 11 Mar 2025

Holdings reported by John Vavricka for Atea Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 82,594 $350,198 $4.24 31 Jan 2026 Direct
Common Stock 82,508 $294,553 $3.57 31 Jan 2026 Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust
Restricted Stock Units 0 $26,775 $3.06 31 Jan 2026 Direct Common Stock
Stock Option (Right to Buy) 119,520 31 Jan 2026 Direct Common Stock

Transactions reported by John Vavricka for Atea Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.